Month: December 2025

Primary Mortgage Market Survey®U.S. weekly average mortgage rates as of 12/31/2025MCLEAN, Va., Dec. 31, 2025 (GLOBE NEWSWIRE) — Freddie Mac (OTCQB: FMCC) today released the results of its Primary Mortgage Market Survey® (PMMS®), showing the 30-year fixed-rate mortgage (FRM) averaged 6.15%. “After starting the year close to 7%, the average 30-year fixed-rate mortgage moved to its lowest level in 2025 this week, an encouraging sign for potential homebuyers heading into the new year,” said Sam Khater, Freddie Mac’s Chief Economist. News FactsThe 30-year FRM averaged 6.15% as of December 31, 2025, down from last week when it averaged 6.18%. A year ago at this time, the 30-year FRM averaged 6.91%. The 15-year FRM averaged 5.44%, down from last week when it averaged 5.50%. A year ago at this time, the 15-year FRM averaged...

Voltalia (Euronext Paris, ISIN code: FR0011995588), an international renewable energy player, announces the start of construction of a strategic cluster in Uzbekistan: Artemisya Storage (100 megawatts / 200 megawatt-hours) and Wind (100 megawatts). This milestone marks a major turning point in the development of the country’s energy storage infrastructure. In March 20251, Voltalia signed a Power Purchase Agreement (PPA) with the Uzbek government during a ceremony at the Élysée Palace. This agreement was decisive for Artemisya, the first hybrid cluster in Central Asia combining solar, wind and storage. The partnership is based on a 25-year electricity sales contract for solar and wind generation, and a 15-year contract for storage: 126 megawatts of solar, 300 megawatts of wind and 100 megawatts / 200 megawatt-hours of batteries. The construction...

Saint-Herblain (France), Pune, (India), December 31, 2025 – Valneva SE (“Valneva” or “the Company”), a specialty vaccine company, and Serum Institute of India (SII), a Cyrus Poonawalla Group company today announced that they have mutually agreed to discontinue their license agreement for Valneva’s single-shot chikungunya vaccine. Valneva´s strategic intent in regaining full rights is to assume direct control over its supply chain and commercialization for endemic high-risk countries, thereby accelerating access for regions most affected by the disease.  Supporting access to the vaccine in low-and-middle-income countries (LMICs) falls within the framework of the funding agreement Valneva signed with the Coalition for Epidemic Preparedness Innovations (CEPI) in July 2024 with co-funding from the European Union1.   About ChikungunyaChikungunya...

Company announcement – No. 27 / 2025 Total number of shares and voting rights in Zealand Pharma as of December 31, 2025 Copenhagen, Denmark, December 31, 2025 – Zealand Pharma A/S (“the Company” or “Zealand Pharma”) (Nasdaq: ZEAL) (CVR-no. 20045078), a biotechnology company transforming the future of metabolic health, today announces, in accordance with section 32 of the Danish Capital Markets Act, the total number of shares and voting rights in the Company at the end of a calendar month during which changes to its share capital have occurred. In Company Announcement No. 25 / 2025 dated December 11, 2025, Zealand Pharma announced a share capital increase due to the exercise of employee warrants. Following this announcement, the table below details the total number of shares and voting rights in Zealand Pharma as of December...

Schindellegi, Switzerland – 31 December 2025 Trifork Group AGCompany announcement no. 62/2025European Regulatory News Reporting of transactions made by persons discharging managerial responsibilities Pursuant to the Market Abuse Regulation Article 19, Trifork Group AG (Swiss company registration number CHE-474.101.854) (“Trifork”) hereby notifies receipt of information of the following transactions made by persons discharging managerial responsibilities in Trifork or persons closely associated with them.1. Details of the person discharging managerial responsibilities/person closely associateda) Name Jørn Larsen2. Reason for the notificationa) Position/status CEO of Trifork Groupb) Initial notification/Amendment Initial notification3. Details of the issuer, emission allowance market participant, auction platform, auctioneer...

TAMPA, Fla., Dec. 31, 2025 (GLOBE NEWSWIRE) — FLUENT Corp. (CSE: FNT.U) (OTCQB: CNTMF) (“FLUENT” or the “Company”), today announced that it has completed the sale of its Pennsylvania operations to HIVE Holdings, Inc., effective December 31, 2025 for US$12.5 million in cash. The proceeds from the transaction were used to reduce FLUENT’s outstanding debt, which is expected to meaningfully enhance its balance sheet, allowing the Company to further concentrate capital and operational resources on its core growth markets. The Company is at arms -length from HIVE Holdings, Inc and no finders’ fees are payable in connection with the sale. “This transaction is an important step forward for FLUENT,” said Dave Vautrin, Interim Chief Executive Officer of FLUENT. “By divesting our Pennsylvania operations, we are strengthening our balance sheet,...

Miami, FL, Dec. 31, 2025 (GLOBE NEWSWIRE) — NextNRG, Inc. (NASDAQ: NXXT), a pioneer in AI-driven energy innovation transforming how energy is produced, managed, and delivered, today announced plans to launch a shareholder rewards program delivering a tangible, real-world benefit through its EzFill platform. Once launched, shareholders will receive a digital fuel-discount coupon token deposited directly into their EzFill mobile app accounts. Upon receipt, the token may be redeemed for one fueling event at a single location and can be applied across multiple vehicles or equipment, including passenger vehicles, commercial fleets, construction equipment, and marine vessels. The coupon token will also be transferable within the EzFill app, allowing shareholders to share the benefit with friends or family while introducing new users...